Sodium Zirconium Cyclosilicate not checked

AstraZeneca

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
Phase 4 trial completes
Trials
3 active
15 in total · 4 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“A 28-day period during which SZC is administered orally once daily (QD) to maintain normokalaemia. A dose titration regimen starting with QD administration of the dose of SZC the participants received TID in the CP will be studied in the MP and continued in the LTMP. The maximum dose that can be used is the calculated body weight equivalent to the 15 g adult dose”In the company’s words, NCT03813407 on ClinicalTrials.gov
Tested for
Hyperkalemia, Hyperkalaemia
Main trialPhase 4
“This is a Phase IV, multicentre, open-label, non-comparative study evaluating Lokelma (sodium zirconium cyclosilicate, SZC) in approximately 100 Indian adults with mild to moderate hyperkalaemia.”In the company’s words, NCT07944378 on ClinicalTrials.gov
Other names
Lokelma TM · SZC · Lokelma

Other drugs for Hyperkalemia

All 3 drugs for Hyperkalemia

Coming up2

Changes1

Last 90 days

Trials15

TrialPhaseCompletesWhat it tests
Phase 4Recruiting 30 Oct 2027 A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia
Phase 3Recruiting 21 Feb 2030 An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Phase 4Terminated 17 Nov 2021 Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia
Phase 4Completed 15 Jul 2024 Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
Phase 4Completed 10 Dec 2024 Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
Phase 3Completed 3 Jan 2022 Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects
Phase 3Terminated 14 Sep 2022 Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
Phase 3Completed 15 Sep 2022 A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
Phase 3Terminated 7 Feb 2024 A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
Phase 3Terminated 7 Mar 2024 Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
Phase 2Terminated 22 May 2020 Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
Phase 1Completed 16 Sep 2021 Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
Phase 3Ended not given Sodium zirconium cyclosilicate to allow liberal fruit and vegetable intake for patients with CKD stage 3b and 4 (LIBERAL study)
Phase 3Ended not given A Randomized Clinical Trial, Multicentre, Open-label, Parallel-group, to define the best Strategy for the management of hEart failure aNd chronic kidney disease among elderly patients with or at high risk of hyperKalemia in spAin by optimizing the use of RAASi with SZC: SENEKA Study
Phase 3Authorised not given Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to standard of care to manage hyperkalemia in patients with chronic kidney disease (CKD)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Sodium Zirconium Cyclosilicate

Following is part of Solo: you see every change to Sodium Zirconium Cyclosilicate the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in